Neonatal exposure to Gross murine leukemia virus results in a profound inhibition of the virusspecific T and B cell responses of adult animals. Animals exposed to virus as neonates exhibit a marked depression in virus-specific T cell function as measured by the virtual absence of in vivo delayed type hypersensitivity responses and in vitro proliferative responses to virally infected stimulator cells. Further, serum obtained from neonatally treated mice failed to either immunoprecipitate viral proteins or neutralize virus in an in vitro plaque assay, suggesting the concurrent induction of a state of B cell hyporesponsiveness . The specificity of this effect at the levels of both T and B cells was demonstrated by the ability ofneonatally treated mice to respond normally after adult challenge with either irrelevant reovirus or influenza virus. The replication of Gross virus within both stromal and lymphocytic compartments of the neonatal thymus suggests that thymic education plays a key role in the induction ofimmunologic nonresponsiveness to viruses. mmunologic nonresponsiveness to autologous molecules and a variety of exogenous antigens can be linked to their presence during neonatal maturation (1-4). The consequences of neonatal exposure to viruses are considerably more variable (5, 6). Mice infected either neonatally or congenitally with lymphocytic choriomeningitis virus (LCMV)' or endogenous ecotropic retroviruses mount potent Ig responses and produce functional CTL precursors (7-9). However, several recent studies have shown that exposure of neonatal mice to Moloney murine leukemia virus significantly reduced the frequency ofMoloney virus-specific CTL precursors and Ig levels (6, 10) . These contrasting results raise important questions concerning the ability of different viruses to induce tolerance, and the contributions of T and B cell components to virus-specific tolerance . To address these questions, the immune response ofmice exposed as neonates to NB-tropic Gross murine leukemia virus (GMuLV) was investigated . Exposure of neonates to GMuLV induces a state ofimmunologic nonresponsiveness that may be linked to intrathymic replication of this retrovirus .
Summary
Neonatal exposure to Gross murine leukemia virus results in a profound inhibition of the virusspecific T and B cell responses of adult animals. Animals exposed to virus as neonates exhibit a marked depression in virus-specific T cell function as measured by the virtual absence of in vivo delayed type hypersensitivity responses and in vitro proliferative responses to virally infected stimulator cells. Further, serum obtained from neonatally treated mice failed to either immunoprecipitate viral proteins or neutralize virus in an in vitro plaque assay, suggesting the concurrent induction of a state of B cell hyporesponsiveness . The specificity of this effect at the levels of both T and B cells was demonstrated by the ability ofneonatally treated mice to respond normally after adult challenge with either irrelevant reovirus or influenza virus. The replication of Gross virus within both stromal and lymphocytic compartments of the neonatal thymus suggests that thymic education plays a key role in the induction ofimmunologic nonresponsiveness to viruses. mmunologic nonresponsiveness to autologous molecules and a variety of exogenous antigens can be linked to their presence during neonatal maturation (1) (2) (3) (4) . The consequences of neonatal exposure to viruses are considerably more variable (5, 6) . Mice infected either neonatally or congenitally with lymphocytic choriomeningitis virus (LCMV)' or endogenous ecotropic retroviruses mount potent Ig responses and produce functional CTL precursors (7) (8) (9) . However, several recent studies have shown that exposure of neonatal mice to Moloney murine leukemia virus significantly reduced the frequency ofMoloney virus-specific CTL precursors and Ig levels (6, 10) . These contrasting results raise important questions concerning the ability of different viruses to induce tolerance, and the contributions of T and B cell components to virus-specific tolerance . To address these questions, the immune response ofmice exposed as neonates to NB-tropic Gross murine leukemia virus (GMuLV) was investigated . Exposure of neonates to GMuLV induces a state ofimmunologic nonresponsiveness that may be linked to intrathymic replication of this retrovirus .
1 Abbreviations used in this paper: DTH, delayed-type hypersensitivity; GMuLV, Gross murine leukemia virus ; HAU, hemagglutinating units; LCMV, lymphocytic choriomeningitis virus; PFU, plaque-forming units ; RT, reverse transcriptase.
Intraperitoneal injection of neonatal mice with GMuLV leads to the development of lymphatic leukemias typified by the presence of thymic lymphomas, and to a unique form ofpersistent infection within the central nervous system white matter (11) (12) (13) . The data reported here demonstrate that neonatal exposure to these murine retroviruses also induced a state of virus-specific T cell nonresponsiveness, characterized by impaired delayed type hypersensitivity and in vitro proliferative responses. Concomitant with this T cell defect was the functional inactivation of virus-specific B cells, as evidenced by the absence ofboth neutralizing and immunoprecipitating antibody. These immunologic defects occur simultaneously with the detection of GMuLV replication within thymic stromal elements. The implication ofthese observations with regard to more general aspects of immunologic tolerance is discussed in the context ofthe specific requirements for viral replication within thymic and lymphoid cells.
Materials and Methods
Mice . 6-8-wk-old BALB/cByj mice (H-2d) were obtained from TheJackson Laboratory, Bar Harbor, ME, and breeding pairs were established. Mice were maintained on standard lab chow and water and libitum. BALB/c nu/nu mice were obtained from the National Cancer Institute, Bethesda, MD, and housed in a germ free facility at the University of Pennsylvania School of Medicine.
Viruses. Two strains of GMuLV were used in these studies: parental NB tropic GMuLV and the WB91 strain of GMuLV (12) . Virus was expanded by passage in Sc-1 cells, a feral mouse embryo fibroblast line (American Type Culture Collection, Rockville, MD). Sc-1 cells were grown in MEM supplemented with 10% FCS and pre-treated with Polybrene (8 hg/ml) (Aldrich Chemical Co ., Milwaukee, WI) for 1 h before addition of virus. To confirm infection of Sc-1 cells, supernatants from confluent monolayers were tested 7-10 d after virus addition for the presence of reverse transcriptase (RT) according to the method of Goff et al . (14) . Supernatants were aliquoted and stored at -70°C. Viral titers were determined by a modified XC cell plaque assay (15) .
Virus-specific neutralizing activity was determined by incubation of virus with medium (control) or test serum at a dilution of 1:5 for 40 min at 37°C, followed by addition to Polybrene-treated Sc-1 cells plated into six-well tissue culture plates (104 cells/well) for XC cell plaque assay. Serum neutralizing activity was expressed as a neutralization index, calculated as the difference in the logio titer of the virus samples with or without serum.
The purified PR8 strain of influenza A virus was prepared and quantitated for hemagglutinatinn activity by Dr. Michael Cancro (University of Pennsylvania) . Reovirus type 3 was prepared from infected L cell monolayers as described previously (16) .
Immunizations. Neonates were injected intraperitoneally with 2 x 103 plaque forming units (PFU) of live GMuLVcontaining culture supernatants within the first 24 h after birth. At 6 wk of age, these animals and age-matched controls were challenged intraperitoneally with 2 x 103 PFU of virus, and in some experiments, with 1,000 hemagglutinating units (HAU) of UV-inactivated influenza virus. Serum was collected by retro-orbital bleeding both before and 8 d after challenge. Samples were allowed to clot, spun for 10 minutes in a micro-centrifuge, serum aspirated, and stored at -20°C.
For delayed type hypersensitivity experiments, mice were immunized intraperitoneally at 6-8 wk of age with virus (2 x 103 retrovirus PFU or 3 x 106 reovirus PFU in 100 A1). All animals were challenged after 6 d with 25 F.1 of virus in one footpad, and 25 Al of media in the contra-lateral footpad. 24 h later, footpad swelling was measured in a blind manner with a Fowler micrometer (Schelinger's, Brooklyn, NY). Responses were expressed as the percentage increase in the thickness of the virally challenged footpad as compared with the media challenged footpad.
RIA for Andinfuenza Antibody. Doubling dilutions of serum were prepared in 20 mM sodium phosphate (pH 7.4), 0.02% sodium azide, 5% horse serum. 20 pl of either standard PR8-specific hybridoma proteins or diluted serum was added to the wells of microtiter plates (Dynatech Laboratories, Inc., Alexandra, VA) previously coated with 20 HAU of purified virus. Antibody binding to adsorbed virus was determined with affinity-purified, I'lllabeled, goat antibody against mouse a, 'y, or A chains, or with rabbit anti-mouse F(ab)z (kindly provided by Dr. Michael Cancro) .
Assayfor Virus-specific Serum Ig. Serum from mice treated with GMuLV and WB91-GV were assayed for virus-specific Ig by binding to the tumor cell lines Kgv and KKC, respectively. Tumor cell lines were originally derived from thymic lymphomas induced by inoculating adult BALB.K mice with these viruses (12, 17 (18) . Cells were then incubated with 500 A1 of lysis buffer (50 mM tris, pH 7.6, containing 0.1% BSA, 300 mM NaCl, 1% Triton X-100, 0.5% NP-40, 10 fag/ml leupeptin, 50 Wg/ml aprotinin, 10 mM iodoacetamide, 0.4 mM sodium orthovanadate, 0.4 mM EDTA, 10 mM NaF, 10 mM sodium pyrophosphate, and 1 mM PMSF) and processed as described previously (IS) . Lysates were pre-cleared by incubating with protein A-Sepharose and then incubated with serum or purified goat anti-Rauscher gp70 at a final dilution of 1:10 for 45 min at 4°C followed by the re-addition of protein A-Sepharose . Pellets were resuspended in electrophoresis loading buffer and analyzed under reducing conditions by SDS-PAGE and autoradiography.
Serum Immune Complex Assay. A solid phase assay designed for the detection of human serumimmune complexes (Sigma Chemical Co., St . Louis, MO) was adapted for measuring murine complexes. Briefly, doubling dilutions of normal mouse serum or serum from mice exposed to virus as neonates were prepared in 200 Al of sample buffer. 5 Al of a solution containing -0 .45-Wg equivalents of human immune complexes per milliliter was added to each sample, and 100 AI of each was then transferred to microtiter wells pre-coated with goat Clq and incubated at room temperature for 20 min. Wells were washed three times, after which 100 pl of a goat anti-human Ig/alkaline phosphatase conjugate was added and incubated at room temperature for 20 min. Wells were again washed three times, 100 pl of substrate solution was added (p-nitrophenyl phosphate, disodium hexahydrate, 1 mg/ml, pH 9.6), incubated at room temperature for 20 min, and the reaction stopped by the addition of 100 Al of a pH 12 alkaline solution . Absorbance at 405 nm was measured with a microplate reader (Bio-Rad Laboratories, Richmond, CA). This assay is sensitive to a serum immune complex concentration corresponding to 20-wg equivalents/ml .
Detection of Tissue-deposited Immune Complexes. Kidneys from 6-8-wk-old neonatally treated or normal mice were removed, placed in TissueTek II OCT compound (LabTek Products, Naperville, IL), and rapidly frozen . Frozen sections 3-4 Am in thickness were cut, mounted on glass slides, and fixed in methanol (-20°C). Sections were incubated with a goat anti-mouse Ig/fluorescein conjugate (Fisher Scientific Co .) diluted 1:200 in 0.5 M Tris, pH 7.6, for 45 min at room temperature and washed extensively. Slides were analyzed on a Nikon Optiphot fluorescence microscope.
Mixed Lymphocyte Reaction. Enriched T cell responder populations were prepared by treating spleen cell suspensions with the mAbs J11d (recognizes a determinant found on a variety of cell types including a majority of B cells) and MKD6 (anti-I-Ad), and a mixture of guinea pig/rabbit complement . Stimulator cells were prepared from the spleens of virally infected animals and irradiated (3,000 rad) . 5 x 105 responder cells were cocultured with 0.3 x (200 Al/well of DMEM supplemented with 10% FCS, 5 x 10 -1 M 2-ME, 100 U/ml penicillin, 100 Ag/ml streptomycin, and 1 mM glutamine) . Cultures were maintained in a humidified atmosphere containing 5% C02 at 37°C for 2 h, and were pulsed for the final 16 h with ['Hlthymidine (1 .0 wCi/well) followed by harvesting and counting.
Thymic Adherent Cell Lines. Thymic cell lines were established from neonatal BALB/c mice injected with 2 x 103 PFU of WB91-GV at birth. After 10 d, thymi were removed, cells dissociated, and the thymic capsule was incubated in 0.1% collagenase (Sigma Chemical Co .) in PBS for 20 min at 37°C . Cell lines were termed NTgV Cl and NTgVCl/T The cells were distributed in cell culture flasks in DMEM supplemented with 10% FCS, 2 MM L-glutamine, 5 x 10 -5 M 2-ME, modified Eagle's medium, nonessential amino acids, sodium pyruvate, and 1 mM Hepes buffer, and maintained at high cell density for several weeks with periodic removal of nonadherent cells. Stromal monolayers of mixed morphology were evident at -3 wk of culture; in some cultures (NTgV Cl/T), enrichment for epithelial cell populations was accomplished by periodic removal of contaminating fibroblasts by brieftreatment with Trypsin-EDTA (Gibco Laboratories, Grand Island, NY).
Viral replication was determined by RT assay as describedpreviously (14) . Controls included culture supernatants from normal d14 BALB/c primary fetal liver cell cultures, a thymic cortical reticular epithelial cell line derived from SV40-transgenic mice designated 1308 .1 (182), or C57SV, an SV40-transformed embryonic stromal cell line (19) .
Results

The Major Immunologic Response o ,f GMuLVinfected Mice
Is to thegp70 Envelope Glycoprotein. The antigenic specificity of the humoral immune response of adult mice challenged with GMuLV was initially evaluated by radioimmunoprecipitation . To identify viral gene products, lysates of I'll surfacelabeled virus-induced tumor cells were first incubated with purified goat Ig raised against the Rauscher virus glycoprotein. This reagent reacts with gp70 molecules encoded by all murine leukemia viruses . As seen in Fig. 1 , a band with an apparent molecular weight of 70,000 was detected upon incubation with immune goat serum (lane 2) compared with normal goat serum (lane 1). The Ig response of normal adult mice to challenge with GMuLV displayed a similar specificity. 
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Incubation of cell lysates with serum taken from a normal 6-wk-old BALB/c mouse 8 d after intraperitoneal injection of GMuLV resulted in the precipitation of a band of 70,000 (lane 4), compared with normal mouse serum (lane 3) . This band was shown to correspond to the viral envelope glycoprotein gp70 by successful pre-clearing of lysates with goat anti-Rauscher gp70, before immunoprecipitation with mouse serum (data not shown) . These results indicate that exposure of normal adult BALB/c mice to intact GMuLV elicits a humoral immune response directed predominantly against the viral gp70 molecule . However, responses to other viral proteins can be detected by this analysis. Over-exposure of the same gels illustrated weak reactivityto proteins with apparent molecular weights of 15,000, 30,000, and 43,000 . These bands are believed to represent the viral proteins p15, p30, and gp43, respectively (20) .
Neonatal Exposure to GMuLV Diminishes the Ability ofAdult
Mice to Mount a Virus-specie Antibody Response. The effect of neonatal exposure to GMuLV on adult immune responsiveness was determined by FACS analysis of serum Ig binding to GMuLV induced tumor cells. The exclusive detection of gp70 in immunoprecipitates of tumor cells, as described above, ensures that FACS analysis detects specific binding of retrovirally encoded molecules . To assess the impact of neonatal exposure to GMuLV, mice were intraperitoneally injected with 2 x 103 PFU of virus at 6-12 h after birth (these were termed neonatally treated mice) or left untreated. Untreated and neonatally treated mice were then challenged by intraperitoneal injection with 2 x 103 PFU of GMuLV at 6-8 wk of age . Serum samples obtained at pre-and post-challenge were incubated with GMuW infected tumor cells over a range of serum dilutions to accurately assess antibody titer. Cells were then incubated with a fluoresceinated goat anti-mouse Ig conjugate, and subsequently analyzed by flow cytofluorometry. Increases in the level of fluorescence between populations of cells treated with equivalent dilutions ofpre-or postchallenge sera reflect the level ofantibody molecules binding viral proteins on the surface of these cells. As shown in Fig.  2 A, there was a 3 .5-fold increase in staining of cells incubated with post-challenge serum compared with pre-immune serum. In contrast, there was no detectable difference in staining when comparing cells incubated with pre-or post-challenge serum from a neonatally treated mouse (Fig. 2 B) . A close comparison of the FACS profiles of pre-bleed sera for the two representative animals shown in Fig. 2 also illustrates that the level of endogenous (i .e., pre-challenge) antiviral antibody was decreased in neonatally treated mice. A compilation of FACS data from 10 mice treated and analyzed in an identical manner to that described in Fig . 2 is shown in Fig. 3 A. Normal mice produced significantly more antibody in response to adult challenge with virus compared with neonatally treated mice. These results are in marked contrast to previous observations with LCMV (7, 21) , and to studies conducted by one of us Q . Korostoff), on the effect of neonatal exposure to the PR8 strain of influenza virus (22) . In this latter instance, neonatal exposure to influenza virus induced a shift in the B cell repertoire without concomitant reduction in the magnitude of the antibody response. The specificity ofthe inhibitory effect of neonatal exposure to GMuLV was examined by intraperitoneal challenge of mice with PR8 . These results (Fig. 3 B) indicate that mice treated neonatally with GMuLV are fully capable of mounting a normal influenza-specific humoral response. Normal mice had Previous studies by Oldstone and colleagues (7, 8, 21 ) have shown that virus-specific antibody may pass undetected due to the sequestration of antibody in the form of circulating or tissue-deposited immune complexes . To address this possibility, the serum and kidneys of mice were examined for the presence of immune complexes, in a manner similar to that described in the LCMV system. There were no detectable differences in the levels of circulating or tissue-deposited immune complexes when comparing normal adult mice with neonatally treated mice rechallenged with GMuLV as adults (data not shown) .
Neonatally Treated Animals Lack both Immunoprecipitating and Neutralizing Antibody Responses. The observation that neonatally treated mice exhibited reduced levels of virus-specific antibody prompted analysis of the physiological significance of this hyporesponsiveness. Representative serum samples were first analyzed for their ability to precipitate viral proteins from lysates of GMuLVinfected cells. As seen in Fig. 4 A, sera from normal adult mice challenged with virus (lanes 1 and 2) contained antibody capable of Immunoprecipitating gp70 from cell lysates. In contrast, sera from neonatally treated mice (lanes 3, 4, and S) failed to immunoprecipitate gp70 or any other viral proteins under the same conditions. Similar immunoprecipitation analysis of tumor cell lysates that were metabolically labeled with 35S-methionine also failed to detect any response to viral proteins (data not shown) . This observation shows that the humoral immune response ofmice exposed to GMuLV as neonates is not redirected towards a nonenvelope viral antigen .
Serum samples were also tested for their ability to neutralize infectious virus by in vitro plaque-forming assays. As 1769 Korostoff et al .
seen in Fig. 4 B, sera from normal adult mice (untreated) challenged with GMuLV contained substantial neutralizing activity. These sera were significantly more effective at neutralizing the virus compared with sera from neonatally treated or naive normal mice, which showed no neutralizing activity. Taken together, these results indicate that exposure of mice to virus as neonates totally abrogates their ability to produce physiologically relevant virus-binding or neutralizing antibody in response to adult challenge with GMuLV . Nude Mice Do NotMount Normal Humoral Responses to Challenge with GMuLV To determine the role of T cells in the generation of normal anti-Gross virus-specific humoral responses, 6-8-wk-old normal BALB/c or male BALB/c nu/nu mice were intraperitoneally injected with GMuLV on days 0 and 8, and bled on days 0, 8, and 16 . The serum samples obtained from these bleeds were analyzed for the presence of GMuLV specific antibody, and for the ability to neutralize virus in the in vitro plaque assay. Although nude mice did mount a virus-specific antibody response to GMuLV challenge, the kinetics as well as the magnitude of this response were markedly different from that seen in normal mice (Fig .  5 A) . A large amount of antivirus antibody could be detected in the sera of normal mice 8 d after primary exposure, and this activity increased to a maximum level at 8 d post-secondary challenge. In contrast, sera from nude mice contained considerably less GMuLVspecific antibody after primary exposure, and failed to show any signs of a secondary response. A marked difference was also detected when the function of anti-GMuLV antibodies in nude mice was examined (Fig. 5 B) . Ig from nude mice was incapable of neutralizing infectious virus, whereas the response of normal mice displayed potent neu- vivo Th cell function . Normal or neonatally treated BALB/c mice were intraperitoneally injected with GMuLV, and after 6 d, animals were challenged by paired footpad injection with either virus or media. DTH responses were measured 24 h later. The data in Fig. 6 A illustrate a significant decrease in the magnitude of DTH responses elicited in neonatally treated mice compared with that of normal mice. The specificity ofthis inhibition was demonstrated by normal DTH responses in the same mice to antigenically irrelevant reovirus (Fig. 6 B) . As a more direct measure ofisolated T cell activity, in vitro proliferative responses ofenriched T cell populations prepared from the spleens ofnormal and neonatally treated mice were measured. Antigen-primed T cells were cocultured with syngeneic, GMuLVinfected, or uninfected spleen cells for 48 h.
[3H]Thymidine was added for the last 16 h of culture, after which cells were harvested and the counts incorporated determined. Data shown in Table 1 demonstrate a significant diminution in the GMuLV proliferative response of enriched T cells from neonatally exposed mice compared with that ofcells from normal mice. Thus, neonatal exposure to GMuLV induces a state of severe T cell nonresponsiveness in adult mice.
Thymic Stromal Cells Support the Replication ofGMuLV In
Viva Previous work has shown that GMuLV infects cells of lymphoid origin within the thymus (23, 24) . Replication of virus within nonlymphoid thymic cells was investigated by measuring RT activity in supernatants from adherent cell lines established from the thymi ofmice infected with GMuLV at birth. As shown in Table 2 , significant levels of RT activity were detected in the supernatants of two such cell lines : NTgVCl and NTgVCl/T Both lines were enriched for thymic stromal cells. NTgVCl/T was further enriched for thymic epithelial cells . RT activity was not detected in supernatants from uninfected cell lines, including 1308.1, a thymic cortical reticular epithelial cell line. lmmunohistochemical analysis of the adherent stromal cell cultures showed that 25-30% of these cells expressed viral gp70 on their cell surface, and that these cells were of a CD4 -/CD8 -/CD3 -phenotype (data not shown). Greater than 95% of cells from both lines reacted with a mAb (ERTR5) that exclusively detects thymic medullary epithelial cells (data not shown) . These data indicate that GMuLV infects and subsequently replicates in nonlymphoid thymic stromal cells.
Analyses of multiple parameters of B and T cell function showed that neonatal exposure of mice to GMuLV dramatically altered immune responses to adult challenge with this virus. Exposure ofnaive BALB/c mice to GMuLV at 6-8 wk of age stimulated a vigorous anti-Gross virus humoral response. The predominant response was towards the viral glycoprotein, gp70, as detected by immunoprecipitation from lysates ofradiolabeled GMuLVinduced tumor cells . The antibody molecules generated are potent at neutralizing infectious virus. It is interesting to note that the antiretrovirus immune response in a naive adult mouse does not necessarily protect an animal from virus infection . Upon immunization with parental GMuLV, BALB/c-H-2k (BALB.K) mice develop a persistent infection despite the generation of virusneutralizing antibody (25) . The basis of this appears to lie with the development of variant viruses that differ within the neutralization-sensitive epitopes expressed on the gp70 molecule. The result of these antigenic variations is that BALB.K mice do not generate an effective antiviral immune response . Preliminary studies suggest that similar types of variants arise in BALB/c and BALB/c-H-26 (BALB.B) mice.
In contrast to the response of naive adult mice, the sera of identically immunized but neonatally treated mice, contain barely detectably levels of antiviral antibody by direct binding analysis, and were not capable of either precipitating viral proteins or neutralizing infectious virus. This effect is antigen specific in that neonatally treated animals exhibited normal humoral responses to influenza virus. The inability to detect normal levels of antiviral antibody in neonatally treated mice was not due to the formation of circulating serum or tissue-deposited immune complexes. These observations demonstrate that the low level of antibody in the serum of hyporesponsive, neonatally treated animals are of extremely low affinity and are therefore oflittle physiologic relevance . This hypothesis is supported by prior descriptions of the presence oflow affinity tolerogen-binding antibody in naturally occurring and experimentally induced models of immunologic nonresponsiveness (26, 27) . These observations also bear on the presence of endogenous antiMuLV antibody (20, 28) . GMuLV crossreactive antibody is present in the serum of naive, normal mice but was not detected in the neonatally treated mice, indicating that neonatal exposure to GMuLV also abrogates the ability to respond to related endogenous MuLVs. The presence of anti-GMuLVspecific antibody in AKR mice (8) , which endogenously express this virus, seems to argue against this hypothesis. However, the presence of maternally transmitted virus-specific antibody and low level of endogenous virus production in newborn AKR mice (29) probably preclude the development of neonatal tolerance.
The B cell hyporesponsiveness seen in neonatally treated mice can be explained by a number of mechanisms, all of which have been demonstrated experimentally by others. Possibilities include the physical elimination (30) or functional silencing of antigen-reactive B cell clones (31, 32) . Determination of the frequency of anti-GMuLVspecific B cell precursors by limiting dilution analysis in normal and neonatally treated mice would resolve this issue. However, the presence oflow but detectable levels of antiviral antibody in the serum of some neonatally treated animals argues against the absolute deletion or silencing of reactive clones in our system . A more likely hypothesis is that B cell hyporesponsiveness is linked to the abrogation of GMuLVspecific T cell function . For example, it has recently been reported that B cell nonresponsiveness in transgenic mice expressing a vesicular stomatitis virus cell membrane-associated glycoprotein is dependent on the loss of T cell help (33) .
To address this possibility, the role of T cells in the generation of a physiologically normal anti-GMuLV antibody response was first determined. These studies showed that nude mice failed to express typical levels of neutralizing antibody and secondary responses after GMuLV challenge, analogous to the response of neonatally treated mice. The inability of serum from nude mice to either neutralize infectious virus, or immunoprecipitate viral antigens (J. Korostoff, unpublished data), suggests that these antibodies are of low affinity, and most likely of the 1A isotype. The weak antibody responses of nude and neonatally treated mice may therefore be due to direct activation of B cells recognizing T cell-independent epitopes within the structure of the gp70 molecule. A similar model was previously described for the nucleocapsid antigen of Hepatitis B virus (34) . The requirement for virus-specific T cell help in the generation of a normal anti-GMuLV antibody response lead to direct analysis of the effect of neonatal exposure to GMuLV on CD4+ T cell function. It has been previously shown that neonatal exposure to Moloney murine leukemia virus resulted in severe reduction in the frequency ofprecursors to virusspecific cytotoxic (CD8+) T cells (10) . In this regard, GMuLV specific DTH and in vitro proliferative responses were determined. Neonatally treated mice did not show a significant DTH response after challenge with GMuLV, despite normal responses of the same mice to antigenically irrelevant reovirus . Further, enriched T cells prepared from the spleens of neonatally treated mice failed to show any proliferative response to GMuLVinfected syngeneic splenocytes despite normal responses to Con A. The observation of antigenspecific CD4+ T cell nonresponsiveness supports the hypothesis that B cell hyporesponsiveness is a reflection of the absence of T cell help (32, 33, 35) .
Recent work from a number of laboratories has shown that T cells can be rendered nonresponsive by intrathymic clonal abortion (36, 37) , functional inactivation (38) , or the induction ofperipheral immunoregulatory phenomena such as suppressor T cells (39) . The data presented here do not allow us to define the mechanism operative in this system . However, by determining the frequency of precursors to GMuLV specific CD4+ T cells, as well as studying the effects of adoptive transfer of cells from neonatally treated mice on the immune competence of normal recipient mice, it will be possible to elucidate the events leading to the T cell nonresponsiveness seen after neonatal exposure to GMuLV
Although our data agree with the results ofothers regarding the induction of neonatally induced nonresponsiveness to retroviruses (10, 40, 41) , other systems have been described in which neonatal or congenital exposure to virus does not alter virus-specific immune responsiveness. The most notable example is LCMV Oldstone and colleagues (reviewed in reference 21) have shown that mice persistently infected with LCMV from birth produce similar amounts of antibody with the same specificities to that found in normal LCMV immune mice. However, most of the antiviral antibody in persistently infected mice was sequestered in the kidneys in the form of immune complexes. Jamieson and Ahmed (9) have also shown that persistently infected animals are capable of mounting antiviral cytotoxic T cell responses after adoptive immunotherapy to reduce the viral load, suggesting that the precursors to these cells are neither clonally deleted nor irreversibly inactivated . Why then does one type of virus, e.g., GMuLV, induce immunologic nonresponsiveness, while another, e.g., LCMV, does not?
It is commonly accepted that the thymus is intimately involved in the induction of T cell nonresponsiveness to selfantigens. Therefore, it follows that the more efficient a molecule is at reaching (and subsequently being processed and presented in) the thymus, the more potent its tolerogenic effect. The analysis of stromal cell lines derived from the thymi of mice neonatally infected with GMuLV showed infection and replication of virus within nonlymphoid cells of the thymus (Table 2) . GMuLV also appears to infect cells at many stages along the T cell differentiation pathway, including the CD4 -/CD8 -precursors that give rise to functionally mature T cells (24) . Preliminary results from our laboratory indicate that at 8 d of age, 5% of thymocytes isolated from neonatally treated mice are infected with GMuLV. This increases to 17% by 3 mo of age. The dual tropism for lymphoid and nonlymphoid thymic cellular compartments allows rapid accumulation ofGMuLV within thymic cells, some of which are intimately involved in shaping the T cell repertoire. The continuous production ofGMuLV throughout the life of a neonatally infected mouse would serve to maintain the nonresponsive state by peripheral inactivation of any high affinity antiviral-specific lymphocytes that escaped tolerance induction (42, 43) .
The presence of LCMVspecific antibody in congenitally and neonatally infected mice can be explained in a reciprocal fashion. LCMV infects mature peripheral CD4+ T cells (44) , and would therefore be predicted to be far less efficient at accumulating in the thymus compared with viruses that infect cells early in the T cell differentiation pathway. It has been shown that <1% of thymocytes from 6-mo-old LCMV carrier mice are actively infected with virus (45) . There is no evidence ofLCMV infection ofthymic stromal elements. Recently, it has been demonstrated that neonatally infected transgenic mice delete CD4+/CD8+ thymocytes that bear a high affinity anti-LCMV TCR a/f3 (46) . The work ofothers indicates, however, that the low level of intrathymic LCMV infection is insufficient to physically eliminate the majority of LCMVspecific T cells (7, 9, 21) . To determine the validity of this model, we are currently analyzing thymocytes and stromal cell lines derived from neonatally infected mice to more accurately quantitate the rate of accumulation of viral material within the thymus. Cloning of GMuMnfected thymic stromal cell lines is also in progress in order to determine the phenotypic characteristics and functional properties of these cells.
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